Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Cell Signal. 2017 Sep 1;40:73–80. doi: 10.1016/j.cellsig.2017.08.011

Fig. 6.

Fig. 6

In vitro enzyme assays confirm that PDE4BT407A is less sensitive to BC54 and rolipram as compared to wild type PDE4B. In vitro enzyme assays using the catalytic domains of wild type PDE4B and PDE4BT407A expressed and purified from E. coli. Values represent averages of inhibition ± S.E.M. from three independent assays carried out at 500nM cAMP substrate concentration.